JACOBS LEVY EQUITY MANAGEMENT, INC
Position in EDIT — Editas Medicine, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,438,303
-$257,334 QoQ
Shares Held
582,309
-29.6% QoQ
Ownership
0.595%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 65.22516395934117.ToString("F0")%
Shared 0.ToString("F0")%
None 34.774836040658826.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,903,019 across 86 Biotechnology names. EDIT ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
214,160 | $165,468,582 | |
| 2 | INCY |
Incyte Corp
|
1,717,978 | $161,696,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
212,204 | $70,211,937 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
789,429 | $51,020,796 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,431,071 | $29,980,937 | |
| 6 | EXEL |
Exelixis, Inc.
|
425,982 | $18,270,367 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,097,189 | $16,260,340 | |
| 8 | ARVN |
Arvinas, Inc.
|
1,441,521 | $15,280,122 |
All Filings in EDIT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,438,303 | 582,309 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,695,637 | 827,140 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,776,079 | 800,023 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $204,252 | 92,842 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $899,679 | 708,409 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,806,733 | 529,834 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,060,939 | 227,182 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $884,018 | 119,140 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,885,307 | 284,828 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $648,148 | 83,096 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $151,053 | 18,354 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $133,963 | 15,103 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,311,369 | 107,138 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $1,439,034 | 75,659 | Shares | Sole | 2022-05-16 | |
| 2020-12-31 | $4,861,777 | 69,345 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,525,961 | 90,020 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,327,572 | 112,494 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,337,949 | 67,471 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||